home / stock / cybn:cc / cybn:cc news


CYBN:CC News and Press, CYBIN INC. From 07/14/22

Stock Information

Company Name: CYBIN INC.
Stock Symbol: CYBN:CC
Market: AQNC

Menu

CYBN:CC CYBN:CC Quote CYBN:CC Short CYBN:CC News CYBN:CC Articles CYBN:CC Message Board
Get CYBN:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

CYBN:CC - Is It Safe to Smoke DMT?

DMT is said to be one of the most potent hallucinogens known to man. Smoking this drug, which is also called the spirit molecule, can cause a range of hallucinations, including visions of alien landscapes, temples, clowns, fairies, sprites, elves and goddesses. Nick Sand, an underground ...

CYBN:CC - Online Companies Offering Mental Health Services Come Under Spotlight

The need for therapists in the United States is currently at an all-time high, with the latest data from the CDC showing about 40% of adults in the country are struggling to find help for their substance abuse or mental health issues because of a therapist shortage. With no physical provid...

CYBN:CC - InvestorNewsBreaks - Cybin Inc.'s (NYSE American: CYBN) (NEO: CYBN) CYB003 Phase 1/2a Clinical Trial Through Clinilabs Begins Enrollment

Clinilabs Drug Development Corporation , a global, full-service contract research organization with deep expertise in central nervous system drug development, today announced commencement of enrollment in a phase 1/2a clinical trial of CYB003. Being developed by Cybin (NYSE American: CYBN)...

CYBN:CC - Clinilabs Drug Development Corporation Begins Enrollment for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder

Clinilabs Drug Development Corporation (“Clinilabs”), a global, full-service contract research organization with deep expertise in central nervous system drug development, announced today that enrollment has begun in a Phase 1/2a clinical trial of CYB003, the first nov...

CYBN:CC - Congressional Leaders Want Studies to be Conducted on Mental Health Benefits of Psychedelics

Initial research on psychedelics back in the 1950s and 1960s found that treatments involving psychedelic drugs could lead to positive mental health outcomes. However, the U.S. government criminalized psychedelics in the late 1960s . The substances remained illegal for decades until a few ...

CYBN:CC - InvestorNewsBreaks - Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study Expected to Accelerate Clinical Development Path of CYB004

Cybin (NYSE American: CYBN) (NEO: CYBN) , a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that, through its wholly-owned subsidiary Cybin IRL Limited, it has completed the acquisition of a phase 1 N,N-dimethyltryptamine (&...

CYBN:CC - Cybin Completes Acquisition of Phase 1 DMT Study from Entheon Biomedical

-- Expected to accelerate clinical development pathway of CYB004 for the potential treatment of anxiety disorders by nine months -- Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) (“ Cybin ” or the “ Company ”), a biopharmaceutical compan...

CYBN:CC - Archaeologists Believe Hidden Andean Passageways Were Most Likely Used During Psychedelic Rituals

In the past few years, archaeological studies have revealed that ancient people may have used recreational drugs in their rituals. According to archaeologists, ancient Andean civilizations may have used hidden passageways to take part in rituals that involved psychedelic drugs. Archaeo...

CYBN:CC - New Study Finds That Probiotics May Be Useful in Fight Against Depression

Gut biome, or the community of bacteria that live in the digestive tract , plays a significant role in overall health. If the balance of healthy and unhealthy bacteria in the stomach and intestines gets out of balance, individuals are likely to develop a variety of issues , including h...

CYBN:CC - NJ Senate President Introduces Psilocybin Legalization Bill Containing Home-Cultivation Provision

New Jersey’s senate president recently filed a bill that would legalize the home cultivation, possession and gifting of psilocybin or magic mushrooms to adults aged 21 and older. The psychedelic reform bill contains provisions that would grant the psychedelics market more freedoms t...

Previous 10 Next 10